|
🐜
|
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris
39 auth.
D. Pathirana,
A. Ormerod,
P. Saiag,
Catherine Smith,
P. Spuls,
A. Nast,
J. Barker,
J. Bos,
G. Burmester,
S. Chimenti,
L. Dubertret,
B. Eberlein,
R. Erdmann,
J. Ferguson,
G. Girolomoni,
...
P. Gisondi,
A. Giunta,
C. Griffiths,
H. Hönigsmann,
M. Hussain,
R. Jobling,
S. Karvonen,
L. Kemény,
I. Kopp,
C. Leonardi,
M. Maccarone,
A. Menter,
U. Mrowietz,
L. Naldi,
T. Nijsten,
Ortonne Jp,
H. Orzechowski,
T. Rantanen,
K. Reich,
N. Reytan,
H. Richards,
H. Thio,
P. Kerkhof,
B. Rzany
|
9 |
2009 |
9
🐜
|
|
🦁
|
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
13 auth.
Catherine Smith,
A. Anstey,
J. Barker,
A. Burden,
R. Chalmers,
D. Chandler,
A. Finlay,
C. Griffiths,
K. Jackson,
N. McHugh,
...
K. McKenna,
N. Reynolds,
A. Ormerod
|
8 |
2009 |
8
🦁
|
|
🐜
|
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC
26 auth.
A. Nast,
P. Gisondi,
A. Ormerod,
P. Saiag,
Catherine Smith,
P. Spuls,
P. Arenberger,
H. Bachelez,
J. Barker,
E. Daudén,
E. Jong,
E. Feist,
A. Jacobs,
R. Jobling,
L. Kemény,
...
M. Maccarone,
U. Mrowietz,
K. Papp,
Carle Paul,
K. Reich,
S. Rosumeck,
T. Talme,
H. Thio,
P. Kerkhof,
R. Werner,
N. Yawalkar
|
8 |
2015 |
8
🐜
|
|
🐜
|
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
15 auth.
M. Bruin-Weller,
D. Thąci,
Catherine Smith,
K. Reich,
M. Cork,
A. Radin,
Q. Zhang,
B. Akinlade,
A. Gadkari,
L. Eckert,
...
T. Hultsch,
Zhen Chen,
G. Pirozzi,
N. Graham,
B. Shumel
|
8 |
2018 |
8
🐜
|
|
🦁
|
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005
13 auth.
Catherine Smith,
A. Anstey,
J. Barker,
A. Burden,
R. Chalmers,
D. Chandler,
A. Finlay,
C. E. M. Grifitths,
K. Jackson,
N. McHugh,
...
K. McKenna,
N. Reynolds,
A. Ormerod
|
8 |
2005 |
8
🦁
|
|
🦁
|
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
23 auth.
Catherine Smith,
Z. Jabbar-Lopez,
Zenas Z N Yiu,
T. Bale,
A. Burden,
L. Coates,
L. Coates,
M. Cruickshank,
T. Hadoke,
E. Macmahon,
...
R. Murphy,
C. Nelson-Piercy,
C. Owen,
R. Parslew,
E. Peleva,
E. Pottinger,
E. Samarasekera,
J. Stoddart,
C. Strudwicke,
V. Venning,
R. Warren,
L. Exton,
M. Mustapa
|
7 |
2017 |
7
🦁
|
|
🐢
|
U.K. guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016
20 auth.
D. Creamer,
S. Walsh,
P. Dziewulski,
L. Exton,
H. Lee,
J. Dart,
Jane Setterfield,
C. Bunker,
M. Ardern-Jones,
K. Watson,
...
G. Wong,
M. Philippidou,
A. Vercueil,
R. V. Martín,
G. Williams,
M. Shah,
David Brown,
P. Williams,
M. Mustapa,
Catherine Smith
|
7 |
2016 |
7
🐢
|
|
🐜
|
European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC
22 auth.
A. Nast,
P. Spuls,
G. Kraaij,
P. Gisondi,
Carle Paul,
A. Ormerod,
P. Saiag,
Catherine Smith,
E. Daudén,
E. Jong,
...
E. Feist,
R. Jobling,
M. Maccarone,
U. Mrowietz,
K. Papp,
K. Reich,
S. Rosumeck,
T. Talme,
H. Thio,
P. Kerkhof,
R. Werner,
C. Dressler
|
7 |
2017 |
7
🐜
|
|
🐜
|
0·03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double‐blind controlled trial
10 auth.
S. Reitamo,
J. Harper,
J. Bos,
F. Cambazard,
C. Bruijnzeel-Koomen,
P. Valk,
...
Catherine Smith,
C. Moss,
A. Dobozy,
R. Palatsi
|
6 |
2004 |
6
🐜
|
|
🐜
|
Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis.
8 auth.
C. Pitzalis,
A. Cauli,
N. Pipitone,
Catherine Smith,
J. Barker,
A. Marchesoni,
...
G. Yanni,
G. Panayi
|
6 |
1996 |
6
🐜
|
|
🐢
|
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
14 auth.
S. Mahil,
N. Wilson,
N. Dand,
N. Reynolds,
N. Reynolds,
C. Griffiths,
R. Emsley,
A. Marsden,
I. Evans,
R. Warren,
...
Deborah D. Stocken,
J. Barker,
A. Burden,
Catherine Smith
|
6 |
2019 |
6
🐢
|
